These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 29107217)

  • 21. Predictive imaging of chemotherapeutic response in a transgenic mouse model of pancreatic cancer.
    Wang P; Yoo B; Sherman S; Mukherjee P; Ross A; Pantazopoulos P; Petkova V; Farrar C; Medarova Z; Moore A
    Int J Cancer; 2016 Aug; 139(3):712-8. PubMed ID: 26996122
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of Gd(III) porphyrin-conjugated chitosan nanoparticles as contrast agents for magnetic resonance imaging.
    Jahanbin T; Sauriat-Dorizon H; Spearman P; Benderbous S; Korri-Youssoufi H
    Mater Sci Eng C Mater Biol Appl; 2015; 52():325-32. PubMed ID: 25953574
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biodegradable human serum albumin nanoparticles as contrast agents for the detection of hepatocellular carcinoma by magnetic resonance imaging.
    Watcharin W; Schmithals C; Pleli T; Köberle V; Korkusuz H; Huebner F; Zeuzem S; Korf HW; Vogl TJ; Rittmeyer C; Terfort A; Piiper A; Gelperina S; Kreuter J
    Eur J Pharm Biopharm; 2014 May; 87(1):132-41. PubMed ID: 24365328
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gadolinium as an MRI contrast agent.
    Kim HK; Lee GH; Chang Y
    Future Med Chem; 2018 Mar; 10(6):639-661. PubMed ID: 29412006
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and characterization of PEGylated Gd2O3 nanoparticles for MRI contrast enhancement.
    Ahrén M; Selegård L; Klasson A; Söderlind F; Abrikossova N; Skoglund C; Bengtsson T; Engström M; Käll PO; Uvdal K
    Langmuir; 2010 Apr; 26(8):5753-62. PubMed ID: 20334417
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Switchable MRI contrast agents based on morphological changes of pH-responsive polymers.
    Okada S; Mizukami S; Kikuchi K
    Bioorg Med Chem; 2012 Jan; 20(2):769-74. PubMed ID: 22206870
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeting Pancreatic Cancer Cells with Peptide-Functionalized Polymeric Magnetic Nanoparticles.
    Zhu X; Lu N; Zhou Y; Xuan S; Zhang J; Giampieri F; Zhang Y; Yang F; Yu R; Battino M; Wang Z
    Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31248076
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Engineered magnetic hybrid nanoparticles with enhanced relaxivity for tumor imaging.
    Aryal S; Key J; Stigliano C; Ananta JS; Zhong M; Decuzzi P
    Biomaterials; 2013 Oct; 34(31):7725-32. PubMed ID: 23871540
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A simple approach to a new T
    Strauch H; Engelmann J; Scheffler K; Mayer HA
    Dalton Trans; 2016 Sep; 45(38):15104-15113. PubMed ID: 27711840
    [TBL] [Abstract][Full Text] [Related]  

  • 30. (1) H-NMR relaxometric studies of interaction between apoptosis specific MRI paramagnetic contrast agents and micellar models of apoptotic cells.
    Van Koninckxloo A; Henoumont C; Laurent S; Muller RN; Vander Elst L
    Magn Reson Chem; 2016 Jul; 54(7):568-74. PubMed ID: 26647764
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gd-functionalised Au nanoparticles as targeted contrast agents in MRI: relaxivity enhancement by polyelectrolyte coating.
    Warsi MF; Adams RW; Duckett SB; Chechik V
    Chem Commun (Camb); 2010 Jan; 46(3):451-3. PubMed ID: 20066322
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Strategies for increasing the sensitivity of gadolinium based MRI contrast agents.
    Caravan P
    Chem Soc Rev; 2006 Jun; 35(6):512-23. PubMed ID: 16729145
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High-relaxivity magnetic resonance imaging (MRI) contrast agent based on supramolecular assembly between a gadolinium chelate, a modified dextran, and poly-beta-cyclodextrin.
    Battistini E; Gianolio E; Gref R; Couvreur P; Fuzerova S; Othman M; Aime S; Badet B; Durand P
    Chemistry; 2008; 14(15):4551-61. PubMed ID: 18386282
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Self-assembled polymeric nanoparticles as new, smart contrast agents for cancer early detection using magnetic resonance imaging.
    Mouffouk F; Simão T; Dornelles DF; Lopes AD; Sau P; Martins J; Abu-Salah KM; Alrokayan SA; Rosa da Costa AM; dos Santos NR
    Int J Nanomedicine; 2015; 10():63-76. PubMed ID: 25565804
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Strategies for increasing relaxivity of gold nanoparticle based MRI contrast agents.
    Warsi MF; Chechik V
    Phys Chem Chem Phys; 2011 May; 13(20):9812-7. PubMed ID: 21503280
    [TBL] [Abstract][Full Text] [Related]  

  • 36. One-pot preparation of hydrophilic manganese oxide nanoparticles as T
    Li J; Wu C; Hou P; Zhang M; Xu K
    Biosens Bioelectron; 2018 Apr; 102():1-8. PubMed ID: 29101783
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detection of hepatocellular carcinoma in transgenic mice by Gd-DTPA- and rhodamine 123-conjugated human serum albumin nanoparticles in T1 magnetic resonance imaging.
    Watcharin W; Schmithals C; Pleli T; Köberle V; Korkusuz H; Hübner F; Waidmann O; Zeuzem S; Korf HW; Terfort A; Gelperina S; Vogl TJ; Kreuter J; Piiper A
    J Control Release; 2015 Feb; 199():63-71. PubMed ID: 25499552
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gadolinium-loaded polymeric nanoparticles modified with Anti-VEGF as multifunctional MRI contrast agents for the diagnosis of liver cancer.
    Liu Y; Chen Z; Liu C; Yu D; Lu Z; Zhang N
    Biomaterials; 2011 Aug; 32(22):5167-76. PubMed ID: 21521627
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gd (III) complex conjugate of low-molecular-weight chitosan as a contrast agent for magnetic resonance/fluorescence dual-modal imaging.
    Huang Y; Boamah PO; Gong J; Zhang Q; Hua M; Ye Y
    Carbohydr Polym; 2016 Jun; 143():288-95. PubMed ID: 27083371
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gd3+ cFLFLFK conjugate for MRI: a targeted contrast agent for FPR1 in inflammation.
    Stasiuk GJ; Smith H; Wylezinska-Arridge M; Tremoleda JL; Trigg W; Luthra SK; Morisson Iveson V; Gavins FN; Long NJ
    Chem Commun (Camb); 2013 Jan; 49(6):564-6. PubMed ID: 23208551
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.